Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Collaboration and integrated digital solutions for improved diabetes care

Reference number
Coordinator Karolinska Institutet - Inst. för molekylärmedicin och kirurgi
Funding from Vinnova SEK 7 130 932
Project duration December 2017 - May 2022
Status Completed
End-of-project report Slutrapport_Swelife-Diabetes 211014.pdf(pdf, 1082 kB) (In Swedish)

Purpose and goal

Thenational project has constructed and validated a tool for electronic informed consent to use in clinical diabetes drug study, and stimulated pediatric diabetes research. Our continuous project in Stockholm, AP2, has aimed at doing diabetes care more individually- and evidence-based. For this purpose we have constructed, in collaboration with Telia, a digital e-health application, Telia Home Care. Using this in primary health has shown improved diabetes control and satisfaction of both patients and diabetes care staff,

Expected results and effects

The use of Telia Home Care as a digital appliction in a number of type 2 diabetic patients in primary care, showed after 3-4 weeks improved blood glucose control. Thus, HbA1c decreased from 60,4 +- 1,1 to 51,8 +- 2,1 mmol/mol (p<0,001). in addition, the use enhanced satisfaction of care among both patients and staff.>

Planned approach and implementation

The work project AP2 was performed at 2 primary care centers, Kista and LIljeholmen, in Region Stockholm. Samples to monitor blood glucose control were monitored initially and at the project end as well as 4 weeks thereafter. Both participating patients and staff were interviewed, and resulting quantitative data were published 2021 in the journal Sustainability.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 1 June 2023

Reference number 2017-05319

Page statistics